EXELDERM (sulconazole nitrate) by Journey Medical is clinical pharmacology sulconazole nitrate is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth in vitro of the common pathogenic dermatophytes including trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum and microsporum canis. Approved for tinea pedis (athlete's foot), tinea cruris, tinea corporis caused by trichophyton rubrum and 4 more indications. First approved in 1989.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
EXELDERM (sulconazole nitrate) is a topical imidazole antifungal cream approved in 1989 for treating dermatophyte infections including tinea pedis, tinea cruris, and tinea corporis, as well as tinea versicolor. It works by inhibiting fungal cell growth across a broad spectrum of common pathogenic fungi including Trichophyton and Malassezia species. The drug has demonstrated excellent safety with no contact sensitization, irritation, or phototoxic reactions in clinical testing.
Minimal commercial support with only $111K in annual Part D spending indicates a mature, low-volume product with limited field infrastructure and team expansion opportunities.
CLINICAL PHARMACOLOGY Sulconazole nitrate is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth in vitro of the common pathogenic dermatophytes including Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum and Microsporum canis. It also…
Worked on EXELDERM at Journey Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWith zero linked job openings and approaching loss-of-exclusivity, EXELDERM offers limited career advancement; roles available are primarily defensive sales and account management focused on maintaining existing market share against generics and OTC alternatives. This is not a growth opportunity within Journey Medical's portfolio.